Lumiera Health Inc. Share Price

Equities

NHP.H

CA5502541066

Pharmaceuticals

Market Closed - Toronto S.E. 07:44:55 19/04/2024 pm IST 5-day change 1st Jan Change
0.005 CAD 0.00% Intraday chart for Lumiera Health Inc. 0.00% 0.00%

Financials

Sales 2021 538K 393K 32.82M Sales 2022 631K 461K 38.46M Capitalization 850K 621K 51.83M
Net income 2021 -1M -731K -60.98M Net income 2022 -2M -1.46M -122M EV / Sales 2021 5.51 x
Net Debt 2021 416K 304K 25.4M Net Debt 2022 1.88M 1.37M 115M EV / Sales 2022 4.33 x
P/E ratio 2021
-1.52 x
P/E ratio 2022
-0.31 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 62.87%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0
0.05
5 years
0.00
Extreme 0
0.26
10 years
0.00
Extreme 0
0.43
More quotes
Managers TitleAgeSince
Director of Finance/CFO 66 18/21/18
Members of the board TitleAgeSince
Chairman - 01/20/01
Director/Board Member - 22/22/22
Director of Finance/CFO 66 18/21/18
More insiders
Lumiera Health Inc. is a Canada-based natural health products company. The principal business of the Company is that of selling natural and homeopathic products. The Company specializes in the development and commercialization of evidence-based botanical products for the healthcare industry. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. It is also developing and commercializing a portfolio of innovative solutions in high growth categories such as sleep-aids and pain management. Its product's portfolio categories such as topical pain relief, sleep, skin care, women's health, & infections. The Company’s products and brands include Holizen, Awaye pain relief cream and Bazzzics. The Holizen portfolio has over 20 products that cover a range of therapeutic needs, including cardiovascular health; stress relief; bones, joints & muscle mobility; energy and immunity.
More about the company